Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Clostridium Difficile Infection · Vancomycin Resistant Enterococci Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Riverside University Health System, Moreno Valley, California, United States
Contact: Study coordinator (Suman B Thapamagar, MBBS) · suman.thapamagar@ruhealth.org · 9514864000
Contact: Study coordinator (Brian Phan, PharmD) · b.pham@ruhealth.org · 9514864000
Contact: Principal Investigator (Suman Thapamagar, MBBS)
Brian Phan, PharmD (Sub-investigator)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of Fecal Microbiota Transplantation

Crohn Disease · Ulcerative Colitis · Celiac Disease

Abroad (travel likely)Recruiting

Hong Kong, Hong Kong

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile · Clostridium Difficile Infections · Clostridium Difficile Infection Recurrence

IsraelRecruitingPHASE3

Huntsville, United States · Chandler, United States

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Clostridium Difficile · Ulcerative Colitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Rome, Italy

Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance

Clostridium Difficile Infections

Abroad (travel likely)Recruiting

Paris, France